All In Biotech

Drug Trial Radar · NCT04237597

Pharmacokinetic Drug-Drug Interaction Study Between K-877 and CSG452 in Healthy Adult Volunteers

Last checked: Nov 19, 2026Latest source record: Sep 22, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

20

Actual

Start

Dec 17, 2019

Primary completion

Jan 31, 2020

Study completion Mar 4, 2020

Sponsor

Lead sponsor
Kowa Research Institute, Inc.Industry
Sponsor type
Industry
First posted
Jan 23, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 45 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

A study to compare the pharmacokinetic(s) of K-877 and CSG452 when each drug is administered alone and when both are administered together.

Conditions

  • Healthy

Interventions

  • K-877Drug

    K-877 tablets

  • CSG452Drug

    CSG452 tablets

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Area under the plasma concentration versus time curve (AUC)Time frame: 0 to 24 hours

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • PPD Development. LP

    Austin, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.